188 related articles for article (PubMed ID: 26269563)
21. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.
You WC; Brown LM; Zhang L; Li JY; Jin ML; Chang YS; Ma JL; Pan KF; Liu WD; Hu Y; Crystal-Mansour S; Pee D; Blot WJ; Fraumeni JF; Xu GW; Gail MH
J Natl Cancer Inst; 2006 Jul; 98(14):974-83. PubMed ID: 16849680
[TBL] [Abstract][Full Text] [Related]
22. Helicobacter pylori-induced inflammation and epigenetic changes during gastric carcinogenesis.
Valenzuela MA; Canales J; Corvalán AH; Quest AF
World J Gastroenterol; 2015 Dec; 21(45):12742-56. PubMed ID: 26668499
[TBL] [Abstract][Full Text] [Related]
23. KRAS mutations predict progression of preneoplastic gastric lesions.
Gong C; Mera R; Bravo JC; Ruiz B; Diaz-Escamilla R; Fontham ET; Correa P; Hunt JD
Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):167-71. PubMed ID: 10067815
[TBL] [Abstract][Full Text] [Related]
24. Global DNA hypomethylation is an early event in Helicobacter pylori-related gastric carcinogenesis.
Compare D; Rocco A; Liguori E; D'Armiento FP; Persico G; Masone S; Coppola-Bottazzi E; Suriani R; Romano M; Nardone G
J Clin Pathol; 2011 Aug; 64(8):677-82. PubMed ID: 21617174
[TBL] [Abstract][Full Text] [Related]
25. Helicobacter pylori infection and development of gastric cancer in Korea: long-term follow-up.
Kim N; Park RY; Cho SI; Lim SH; Lee KH; Lee W; Kang HM; Lee HS; Jung HC; Song IS
J Clin Gastroenterol; 2008; 42(5):448-54. PubMed ID: 18344895
[TBL] [Abstract][Full Text] [Related]
26. Helicobacter pylori eradication prevents extension of intestinalization even in the high-risk group for gastric cancer.
Shiotani A; Nishi R; Uedo N; Iishi H; Tsutsui H; Ishii M; Imamura H; Kamada T; Hata J; Haruma K
Digestion; 2010; 81(4):223-30. PubMed ID: 20110706
[TBL] [Abstract][Full Text] [Related]
27. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance.
Liu KS; Wong IO; Leung WK
World J Gastroenterol; 2016 Jan; 22(3):1311-20. PubMed ID: 26811668
[TBL] [Abstract][Full Text] [Related]
28. Changes of gene expression in gastric preneoplasia following Helicobacter pylori eradication therapy.
Tsai CJ; Herrera-Goepfert R; Tibshirani RJ; Yang S; Mohar A; Guarner J; Parsonnet J
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):272-80. PubMed ID: 16492915
[TBL] [Abstract][Full Text] [Related]
29. Long-Term Effects of
Han SJ; Kim SG; Lim JH; Choi JM; Oh S; Park JY; Kim J; Kim JS; Jung HC
Gut Liver; 2018 Mar; 12(2):133-141. PubMed ID: 29069890
[TBL] [Abstract][Full Text] [Related]
30. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer.
Yu J; Cheng YY; Tao Q; Cheung KF; Lam CN; Geng H; Tian LW; Wong YP; Tong JH; Ying JM; Jin H; To KF; Chan FK; Sung JJ
Gastroenterology; 2009 Feb; 136(2):640-51.e1. PubMed ID: 19084528
[TBL] [Abstract][Full Text] [Related]
31. Differentially localized survivin and STAT3 as markers of gastric cancer progression: Association with Helicobacter pylori.
Pandey A; Tripathi SC; Shukla S; Mahata S; Vishnoi K; Misra SP; Misra V; Mitra S; Dwivedi M; Bharti AC
Cancer Rep (Hoboken); 2018 Jun; 1(1):e1004. PubMed ID: 32729225
[TBL] [Abstract][Full Text] [Related]
32. Chemoprevention of precancerous gastric lesions with antioxidant vitamin supplementation: a randomized trial in a high-risk population.
Plummer M; Vivas J; Lopez G; Bravo JC; Peraza S; Carillo E; Cano E; Castro D; Andrade O; Sánchez V; Garcia R; Buiatti E; Aebischer C; Franceschi S; Oliver W; Muñoz N
J Natl Cancer Inst; 2007 Jan; 99(2):137-46. PubMed ID: 17227997
[TBL] [Abstract][Full Text] [Related]
33. Novel epigenetic markers for gastric cancer risk stratification in individuals after Helicobacter pylori eradication.
Maeda M; Yamashita S; Shimazu T; Iida N; Takeshima H; Nakajima T; Oda I; Nanjo S; Kusano C; Mori A; Moro H; Yamada H; Tsugane S; Sugiyama T; Sakai Y; Ushijima T
Gastric Cancer; 2018 Sep; 21(5):745-755. PubMed ID: 29427040
[TBL] [Abstract][Full Text] [Related]
34. Prediction of the risk for gastric cancer using candidate methylation markers in the non-neoplastic gastric mucosae.
Shin CM; Kim N; Park JH; Kang GH; Kim JS; Jung HC; Song IS
J Pathol; 2012 Mar; 226(4):654-65. PubMed ID: 22252584
[TBL] [Abstract][Full Text] [Related]
35. OLGA can guard the barn.
Rugge M; de Boni M; Pennelli G; Mescoli C; Graham DY
Am J Gastroenterol; 2009 Dec; 104(12):3099; author reply 3101-2. PubMed ID: 19956125
[No Abstract] [Full Text] [Related]
36. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy.
Correa P; Fontham ET; Bravo JC; Bravo LE; Ruiz B; Zarama G; Realpe JL; Malcom GT; Li D; Johnson WD; Mera R
J Natl Cancer Inst; 2000 Dec; 92(23):1881-8. PubMed ID: 11106679
[TBL] [Abstract][Full Text] [Related]
37. Promoter methylation of p16 associated with Helicobacter pylori infection in precancerous gastric lesions: a population-based study.
Dong CX; Deng DJ; Pan KF; Zhang L; Zhang Y; Zhou J; You WC
Int J Cancer; 2009 Jan; 124(2):434-9. PubMed ID: 18821580
[TBL] [Abstract][Full Text] [Related]
38. The overmethylated genes in Helicobacter pylori-infected gastric mucosa are demethylated in gastric cancers.
Hong SJ; Oh JH; Jeon EJ; Min KO; Kang MI; Choi SW; Rhyu MG
BMC Gastroenterol; 2010 Nov; 10():137. PubMed ID: 21092120
[TBL] [Abstract][Full Text] [Related]
39. Genetic factors in the development of gastric precancerous lesions--a role of Helicobacter pylori ?
Jablonská M; Chlumská A
J Physiol Paris; 2001; 95(1-6):477-81. PubMed ID: 11595478
[TBL] [Abstract][Full Text] [Related]
40. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions.
Wong BC; Zhang L; Ma JL; Pan KF; Li JY; Shen L; Liu WD; Feng GS; Zhang XD; Li J; Lu AP; Xia HH; Lam S; You WC
Gut; 2012 Jun; 61(6):812-8. PubMed ID: 21917649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
